We are live on ! Find out more
IGC icon

IGC Pharma
IGC

8 hedge funds and large institutions have $147K invested in IGC Pharma in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1,125% more capital invested

Capital invested by funds: $12K → $147K (+$135K)

100% more funds holding

Funds holding: 4 → 8 (+4)

Holders
8
Holders Change
+4
Holders Change %
+100%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$47.1K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$8.7K
3
VKH
Virtu KCG Holdings
New York
+$7.91K
4
TSS
Two Sigma Securities
New York
+$4.19K
5
UBS Group
UBS Group
Switzerland
+$915

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$87K +$47.1K +155,414 +1,225%
VKH
2
Virtu KCG Holdings
New York
$28K +$7.91K +26,116 +94%
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$15K +$8.7K +28,727 New
UBS Group
4
UBS Group
Switzerland
$7K +$915 +3,023 +30%
TSS
5
Two Sigma Securities
New York
$7K +$4.19K +13,848 New
LTFS
6
Ladenburg Thalmann Financial Services
Florida
$1K – – –
GI
7
Gradient Investments
Minnesota
$1K +$606 +2,000 New
Creative Planning
8
Creative Planning
Kansas
$1K +$621 +2,050 New

IGC Hedge Fund Activity: Q1 2016 in Review

8 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in IGC Pharma (IGC) for Q1 2016, worth a combined $147K — up 1,125% from $12K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new IGC positions and 0 closed out — a net gain of 4 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $47.1K.

  • 8 institutional investors held IGC Pharma (IGC) as of Q1 2016, up from 4 in Q4 2015.
  • Funds reported $147K of IGC Pharma stock for Q1 2016, up 1,125% quarter-over-quarter.
  • 4 funds opened new IGC Pharma positions in Q1 2016 and 0 closed out, a net change of +4 holders.
  • The largest IGC Pharma buyer in Q1 2016 was Citadel Advisors, an estimated $47.1K added.

Based on aggregated 13F filings for Q1 2016.